Impact of absolute lymphocyte count upon admission to ICU on 28-day mortality in sepsis patients in ICU Authors: DingJun Zhong, Ling Zhao Published: 2026 ABSTRACT BackgroundSepsis is associated with high mortality and poor prognosis in critically ill patients, posing a severe threat to global public health. The first absolute lymphocyte count (FALC) upon admission to the ICU, reflecting the initial state of the immune system, has emerged as a potential prognostic indicator in various critical illnesses. However, its specific role and predictive value in assessing 28-day mortality among sepsis patients in the ICU remain incompletely understood, with existing studies showing limitations in sample size and verification dimensions.MethodsData of ICU patients (18 1×109/L, the risk tended to be stable. When FALC < 0.5×109/L, there was a risk of death. It further confirmed that the protective effect of FALC on death risk has a threshold effect and is a non-linear relationship. Restricted cubic spline (RCS) prediction plot showing the nonlinear relationship between FALC (cells/uL) and hazard ratio (95% CI), with both overall (P < 0.001) and nonlinear (P < 0.001) effects being statistically significant. Discussion In this large-scale retrospective study utilizing the MIMIC-IV(2.0) database, we systematically demonstrated that the first absolute lymphocyte count (FALC) upon ICU admission is an independent and robust predictor of 28-day mortality in sepsis patients. Through multi-dimensional statistical validations, including Kaplan-Meier survival analysis, univariate/multivariate Cox regression, restricted cubic splines (RCS), and Cox regression ROC curves, we identified a non-linear negative association between FALC and mortality risk: when FALC is below 1×109/L, the risk of death increases sharply; beyond this threshold, the risk stabilizes, highlighting a critical “threshold effect” in its prognostic value. This finding aligns with the pathophysiological mechanisms of sepsis-induced immune dysfunction—specifically, the profound immune suppression characterized by excessive lymphocyte apoptosis, immune exhaustion, and impaired T-cell function (11). Such mechanisms directly contribute to the observed lymphopenia, as sepsis triggers a cascade of pro-inflammatory cytokines that disrupt lymphocyte homeostasis, while mitochondrial dysfunction and oxidative stress further accelerate lymphocyte loss (12, 13). Notably, our data clarify that the relationship between FALC and sepsis outcomes is not simply linear, a nuance overlooked in previous small-sample studies, thereby offering novel insights into how immune cell depletion drives poor prognosis in sepsis. Consistent with a recent study by Huang et al. (2025), which also leveraged the MIMIC-IV database to explore the prognostic role of absolute lymphocyte count (ALC) in sepsis, our findings confirm that lymphocyte count (as FALC in our research) is an independent predictor of mortality—their multivariate Cox analysis reported an HR of 0.88 (P < 0.001) for ALC, while our univariate analysis yielded an HR of 0.62 (P < 0.001) for FALC, both underscoring the protective effect of higher lymphocyte counts. However, Huang et al. focused on integrating ALC into the SOFA score to enhance prognostic accuracy, demonstrating improved area under the receiver operating characteristic curve for 28-day (0.680 vs. 0.664) and 90-day (0.666 vs. 0.647) mortality compared to the original SOFA score. In contrast, our study uniquely emphasizes the non-linear “threshold effect” of FALC (1×109/L), a nuance not explicitly addressed in their ALC-quartile-based scoring system. While both studies validate ALC’s clinical utility, ours provides a precise risk stratification threshold, whereas the ALC-SOFA score offers a comprehensive organ+immune integrated tool—highlighting the complementary value of ALC in sepsis prognosis. Additionally, Huang et al. noted that ALC-SOFA’s predictive advantage was absent in immunocompromised patients, which aligns with our recognition of the need for subgroup-specific validation of FALC’s utility (14). Our focus on admission FALC as a prognostic marker also complements Chen et al.’s (2024) retrospective big data study, which emphasized the predictive superiority of dynamic ALC changes—specifically, day 7 ALC had the highest AUC for 90-day mortality (cut-off value: 1.0×109/L) and outperformed the SOFA score in severely ill (SOFA ≥ 6) and young (<60 years) patients. Chen et al. highlighted that dynamic ALC trajectories better reflect immune suppression kinetics, a point we also acknowledge in our future research directions. However, our study identifies that a single admission FALC measurement still holds robust predictive value for 28-day mortality, with a consistent threshold (1×109/L) to that of Chen et al.’s day 7 ALC cut-off—suggesting that both early static and late dynamic ALC measurements converge on a critical lymphopenia threshold for poor outcomes. Notably, Chen et al. used multiple machine learning models to validate ALC’s additive value, while our RCS analysis reveals the non-linear nature of FALC’s association with mortality—an aspect not fully explored in their linear HR-based analysis. Together, these studies demonstrate that ALC’s prognostic power is retained across both static (admission) and dynamic (longitudinal) measurements, with our work specifying the early threshold effect and Chen et al. emphasizing long-term trajectory value (8). Clinically, the non-linear predictive value of FALC carries substantial implications for optimizing sepsis management, particularly in addressing immune suppression. For patients with FALC < 1×109/L early intervention should prioritize reversing immune paralysis: this includes monitoring T-cell subsets (e.g., CD4+/CD8+ ratios) to quantify immune depletion, considering administering immunomodulators to restore T-cell function (15–17). In contrast, patients with medium to high FALC may retain relatively intact immune competence, making aggressive infection source control and targeted anti-infective therapy more critical to avoid exacerbating immune suppression through overtreatment (18, 19). As a readily accessible and cost-effective biomarker, FALC bridges the gap between bench and bedside, enabling clinicians to stratify patients based on immune status and tailor interventions to preserve or restore immune homeostasis—ultimately improving overall survival and reducing the burden of severe sepsis (20, 21). Future research should focus on several directions to translate these findings into broader clinical practice, with a particular emphasis on immune mechanisms. First, prospective cohort studies tracking dynamic changes in FALC are warranted, as such trajectories may better reflect the kinetics of immune suppression—including the transition from hyperinflammation to immune exhaustion—and enhance prognostic accuracy. Meanwhile, there are also studies elaborating that lymphopenia in sepsis patients, as a dynamic indicator, can better predict the condition and prognosis of sepsis patients (22, 23). Second, integrating FALC with other immune-related indicators such as neutrophil-to-lymphocyte ratio, procalcitonin, or cytokine profiles could establish more comprehensive models to capture the complexity of immune dysregulation, addressing the limitations of single-marker prediction (24–26). Third, subgroup analyses in specific populations are needed to explore how immune cell dynamics vary across contexts and refine FALC’s predictive utility. Finally, interventional studies targeting FALC-related immune mechanisms—such as evaluating whether enhancing lymphocyte survival or restoring T-cell function reduces mortality—will help validate the causal link between lymphopenia, immune suppression, and sepsis outcomes, promoting the translation of basic immunology research into clinical benefits. Fourth, continuous monitoring of absolute lymphocyte count (ALC) may offer advantages over a single admission-only measurement. Dynamic tracking of ALC changes enables real-time reflection of fluctuations in immune status, such as the progression of immunosuppression, therapeutic response, and risk of exhaustion, thereby providing more precise temporal evidence for individualized interventions and addressing the limitations of single measurements. Conclusion FALC upon ICU admission represents a promising tool for early risk stratification and treatment guidance in sepsis, with its non-linear association with mortality directly reflecting the dynamics of immune suppression and lymphocyte depletion. Its clinical utility underscores the importance of individualized immune assessment.